752 related articles for article (PubMed ID: 17022737)
21. [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].
Saito VM; Wotjak CT; Moreira FA
Braz J Psychiatry; 2010 May; 32 Suppl 1():S7-14. PubMed ID: 20512266
[TBL] [Abstract][Full Text] [Related]
22. The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview.
Barna I; Zelena D
Endocr Regul; 2012 Apr; 46(2):107-24. PubMed ID: 22540859
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoids.
Grotenhermen F
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
Gertsch J
Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
[TBL] [Abstract][Full Text] [Related]
25. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid system as a potential target for drug development in the treatment of cardiovascular disease.
Mendizábal VE; Adler-Graschinsky E
Curr Vasc Pharmacol; 2003 Oct; 1(3):301-13. PubMed ID: 15320476
[TBL] [Abstract][Full Text] [Related]
27. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.
Murillo-Rodriguez E; Poot-Ake A; Arias-Carrion O; Pacheco-Pantoja E; Fuente-Ortegon Ade L; Arankowsky-Sandoval G
Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):189-96. PubMed ID: 21919868
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of the endocannabinoid system in the brain.
Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
[TBL] [Abstract][Full Text] [Related]
29. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Martin BR
Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
[TBL] [Abstract][Full Text] [Related]
30. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
31. The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses.
Bisogno T; Di Marzo V
Curr Pharm Des; 2008; 14(23):2299-3305. PubMed ID: 18781980
[TBL] [Abstract][Full Text] [Related]
32. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
Fowler CJ
Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
[TBL] [Abstract][Full Text] [Related]
33. Phytocannabinoids and endocannabinoids.
Fisar Z
Curr Drug Abuse Rev; 2009 Jan; 2(1):51-75. PubMed ID: 19630737
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
35. The endocannabinoid system as an emerging target of pharmacotherapy.
Pacher P; Bátkai S; Kunos G
Pharmacol Rev; 2006 Sep; 58(3):389-462. PubMed ID: 16968947
[TBL] [Abstract][Full Text] [Related]
36. Signaling via CNS cannabinoid receptors.
Mackie K
Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S60-5. PubMed ID: 18336996
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid signaling in health and disease.
Lu Y; Anderson HD
Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
[TBL] [Abstract][Full Text] [Related]
38. Endocannabinoid mechanisms of pain modulation.
Hohmann AG; Suplita RL
AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
[TBL] [Abstract][Full Text] [Related]
39. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
Bisogno T; Di Marzo V
CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
